Showing results (231-240 of 274) with videos related to

Sort By:
Pageof 28
Nature Communications|April 1, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinomaTibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
American Journal of Human Genetics|May 9, 2024
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regionsEileen O Dareng, Simon G Coetzee, Jonathan P Tyrer, et al.
Carcinogenesis|October 2, 2015
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancerKate Lawrenson, Edwin S Iversen, Jonathan Tyrer, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinomaTibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 26, 2015
Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer RiskSiddhartha P Kar, Jonathan P Tyrer, Qiyuan Li, et al.
Journal of Genetics and Genome Research|January 26, 2016
Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)Heather S L Jim, Hui-Yi Lin, Jonathan P Tyrer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 4, 2020
Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both CancersDylan M Glubb, Deborah J Thompson, Katja K H Aben, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2012
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriersYuan C Ding, Lesley McGuffog, Sue Healey, et al.
Pageof 28